Pharmaceuticals December 7, 2023
The already massive GLP-1 obesity drug segment might have gained a major future competitor last week, following Roche’s acquisition of weight loss biotech Carmot Therapeutics.
Surgeries & Interventions December 4, 2023
The left atrial appendage device space became far more competitive last week, following the launch of Medtronic’s Penditure LAA exclusion system and Johnson & Johnson MedTech’s acquisition of LAAX device company Laminar.
Cardiology December 4, 2023
In this Cardiac Wire Q&A, we sat down with AccurKardia CEO Juan C Jimenez and COO Mohamed Sadeq Ali to discuss ECG automation’s massive potential to improve clinical efficiency and care outcomes.